Literature DB >> 15256407

Mining HIV protease cleavage data using genetic programming with a sum-product function.

Zheng Rong Yang1, Andrew R Dalby, Jing Qiu.   

Abstract

MOTIVATION: In order to design effective HIV inhibitors, studying and understanding the mechanism of HIV protease cleavage specification is critical. Various methods have been developed to explore the specificity of HIV protease cleavage activity. However, success in both extracting discriminant rules and maintaining high prediction accuracy is still challenging. The earlier study had employed genetic programming with a min-max scoring function to extract discriminant rules with success. However, the decision will finally be degenerated to one residue making further improvement of the prediction accuracy difficult. The challenge of revising the min-max scoring function so as to improve the prediction accuracy motivated this study.
RESULTS: This paper has designed a new scoring function called a sum-product function for extracting HIV protease cleavage discriminant rules using genetic programming methods. The experiments show that the new scoring function is superior to the min-max scoring function. AVAILABILITY: The software package can be obtained by request to Dr Zheng Rong Yang.

Mesh:

Substances:

Year:  2004        PMID: 15256407     DOI: 10.1093/bioinformatics/bth414

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  2 in total

1.  Comprehensive bioinformatic analysis of the specificity of human immunodeficiency virus type 1 protease.

Authors:  Liwen You; Daniel Garwicz; Thorsteinn Rögnvaldsson
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

2.  How to find simple and accurate rules for viral protease cleavage specificities.

Authors:  Thorsteinn Rögnvaldsson; Terence A Etchells; Liwen You; Daniel Garwicz; Ian Jarman; Paulo J G Lisboa
Journal:  BMC Bioinformatics       Date:  2009-05-16       Impact factor: 3.169

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.